IGF2BP3 and hepatocellular carcinoma: To understand the mechanisms underlying the aberrant upregulation of IGF2BP3 in HCC tissues, we examined the correlation between the expression and methylation of IGF2BP3. A negative correlation was observed between IGF2BP3 expression and the methylation of multiple sites in the IGF2BP3 promoter (Fig. 6A).